Tumor-associated macrophages: role in cancer development and therapeutic implications
A Salmaninejad, SF Valilou, A Soltani, S Ahmadi… - Cellular oncology, 2019 - Springer
Abstract Background Tumor-associated macrophages (TAMs) are known to play important
roles in the initiation and progression of human cancers, as well as in angiogenesis. TAMs …
roles in the initiation and progression of human cancers, as well as in angiogenesis. TAMs …
Preclinical models for drug discovery for metastatic disease
Despite many advances, metastatic disease remains essentially uncurable. Thus, there is an
urgent need to better understand mechanisms that promote metastasis, drive tumor …
urgent need to better understand mechanisms that promote metastasis, drive tumor …
Circulating cells with macrophage-like characteristics in cancer: the importance of circulating neoplastic-immune hybrid cells in cancer
Simple Summary In cancer, disseminated neoplastic cells circulating in blood are a source
of tumor DNA, RNA, and protein, which can be harnessed to diagnose, monitor, and better …
of tumor DNA, RNA, and protein, which can be harnessed to diagnose, monitor, and better …
Universal cancer screening: revolutionary, rational, and realizable
DA Ahlquist - NPJ precision oncology, 2018 - nature.com
Cancer remains the second leading cause of mortality worldwide, and overall cancer-related
deaths are increasing. Despite the survival benefit from early detection, screening has to …
deaths are increasing. Despite the survival benefit from early detection, screening has to …
Sequential tracking of PD-L1 expression and RAD50 induction in circulating tumor and stromal cells of lung cancer patients undergoing radiotherapy
Purpose: Evidence suggests that PD-L1 can be induced with radiotherapy and may be an
immune escape mechanism in cancer. Monitoring this response is limited, as repetitive …
immune escape mechanism in cancer. Monitoring this response is limited, as repetitive …
Tumor-cell–macrophage fusion cells as liquid biomarkers and tumor enhancers in cancer
Y Manjunath, D Porciani, JB Mitchem… - International journal of …, 2020 - mdpi.com
Although molecular mechanisms driving tumor progression have been extensively studied,
the biological nature of the various populations of circulating tumor cells (CTCs) within the …
the biological nature of the various populations of circulating tumor cells (CTCs) within the …
The interplay between circulating tumor cells and the immune system: from immune escape to cancer immunotherapy
K Leone, C Poggiana, R Zamarchi - Diagnostics, 2018 - mdpi.com
Circulating tumor cells (CTCs) have aroused increasing interest not only in mechanistic
studies of metastasis, but also for translational applications, such as patient monitoring …
studies of metastasis, but also for translational applications, such as patient monitoring …
The life cycle of polyploid giant cancer cells and dormancy in cancer: Opportunities for novel therapeutic interventions
Recent data suggest that most genotoxic agents in cancer therapy can lead to shock of
genome and increase in cell size, which leads whole genome duplication or multiplication …
genome and increase in cell size, which leads whole genome duplication or multiplication …
[HTML][HTML] Roles of cell fusion, hybridization and polyploid cell formation in cancer metastasis
I Shabo, J Svanvik, A Lindström… - World journal of …, 2020 - ncbi.nlm.nih.gov
Cell-cell fusion is a normal biological process playing essential roles in organ formation and
tissue differentiation, repair and regeneration. Through cell fusion somatic cells undergo …
tissue differentiation, repair and regeneration. Through cell fusion somatic cells undergo …
Monitoring PD-L1 expression on circulating tumor–associated cells in recurrent metastatic non–small-cell lung carcinoma predicts response to immunotherapy with …
JA Moran, DL Adams, MJ Edelman, P Lopez… - JCO precision …, 2022 - ascopubs.org
PURPOSE Current diagnostic methods to determine programmed death 1 (PD-1) receptor
and its ligand (PD-L1)/PD-1 immunotherapy (immune checkpoint inhibitor [ICI]) efficacy in …
and its ligand (PD-L1)/PD-1 immunotherapy (immune checkpoint inhibitor [ICI]) efficacy in …